Kelly Kearney
Director, Investor Relations and Communications
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
As Director of Investor Relations and Communications, Kelly plays a pivotal role in ensuring Psy maintains strong relationships with its investors while effectively communicating Psy’s compelling mission and vision to the broader community.
Prior to joining Psy, Kelly led brand and digital strategy for healthcare clients at Closerlook, a member of Fishawack Health, and Wunderman Thompson. Her experience includes developing and executing comprehensive marketing strategies for pharmaceutical brands at various stages of product lifecycle management. Kelly’s unwavering dedication to enhancing treatments for psychiatric and neurodegenerative disorders is driven by her deep compassion for patients and their families.
Kelly received her BA in History of Art and Corporate Strategy from Vanderbilt University. She is nearing completion of her MBA with a concentration in Health Sector Management from Boston University Questrom School of Business.